Jarrett Jennifer bought DMRA
September 25, 2026 · Form 4 insider transaction
Jarrett Jennifer bought 12,500 shares of Damora Therapeutics, Inc. at $20.23 per share, a transaction worth $252.9K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.
Footnotes
Represents shares purchased on the open market at prevailing market prices using personal funds.; The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.10 to $20.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.; Includes 500,000 restricted stock units ("RSUs") previously granted to the Reporting Person. Each RSU represents the right to receive, at settlement, one ordinary share of the Issuer.